Concerns over 'designer babies' and embryo editing startups
New capital is flowing into the 'designer baby' industry, despite past failures, raising ethical concerns about embryo editing startups and their implications.
Background
Advances in genetic technology have fueled a global debate about the ethics of human embryo editing. Scientists and policymakers grapple with the potential for treating genetic diseases versus concerns about altering the human germline and creating 'designer babies.' International regulations vary, leading to a complex landscape for research and commercial ventures.
Quorum · collective opinions
Debate over 'designer baby' industry and embryo editing
First report 1h agoLast update 1h agoThe 'designer baby' industry persists with new funding, even after the collapse of several startups.
Concerns about 'designer babies' and embryo editing
First report 1h agoLast update 1h agoThe 'designer baby' industry continues to attract investment despite previous startup collapses and a lack of scientific breakthroughs.
iWitness comments
No comments yet — be the first to weigh in.